RYTM
Price
$56.07
Change
-$1.67 (-2.89%)
Updated
Feb 21 closing price
Capitalization
3.44B
3 days until earnings call
TNGX
Price
$2.36
Change
-$0.07 (-2.88%)
Updated
Feb 21 closing price
Capitalization
252.97M
36 days until earnings call
Ad is loading...

RYTM vs TNGX

Header iconRYTM vs TNGX Comparison
Open Charts RYTM vs TNGXBanner chart's image
Rhythm Pharmaceuticals
Price$56.07
Change-$1.67 (-2.89%)
Volume$420.18K
Capitalization3.44B
Tango Therapeutics
Price$2.36
Change-$0.07 (-2.88%)
Volume$547.26K
Capitalization252.97M
RYTM vs TNGX Comparison Chart
Loading...
RYTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TNGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RYTM vs. TNGX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYTM is a Buy and TNGX is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (RYTM: $57.55 vs. TNGX: $2.43)
Brand notoriety: RYTM and TNGX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RYTM: 83% vs. TNGX: 69%
Market capitalization -- RYTM: $3.45B vs. TNGX: $253.51M
RYTM [@Biotechnology] is valued at $3.45B. TNGX’s [@Biotechnology] market capitalization is $253.51M. The market cap for tickers in the [@Biotechnology] industry ranges from $393.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RYTM’s FA Score shows that 1 FA rating(s) are green whileTNGX’s FA Score has 1 green FA rating(s).

  • RYTM’s FA Score: 1 green, 4 red.
  • TNGX’s FA Score: 1 green, 4 red.
According to our system of comparison, RYTM is a better buy in the long-term than TNGX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RYTM’s TA Score shows that 5 TA indicator(s) are bullish while TNGX’s TA Score has 3 bullish TA indicator(s).

  • RYTM’s TA Score: 5 bullish, 3 bearish.
  • TNGX’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, RYTM is a better buy in the short-term than TNGX.

Price Growth

RYTM (@Biotechnology) experienced а -0.05% price change this week, while TNGX (@Biotechnology) price change was -2.41% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.27%. For the same industry, the average monthly price growth was +3.99%, and the average quarterly price growth was +2.35%.

Reported Earning Dates

RYTM is expected to report earnings on May 06, 2025.

TNGX is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (+4.27% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RYTM($3.44B) has a higher market cap than TNGX($253M). RYTM YTD gains are higher at: 2.805 vs. TNGX (-21.359). TNGX has higher annual earnings (EBITDA): -137.2M vs. RYTM (-237.01M). RYTM (298M) and TNGX (293M) have equal amount of cash in the bank . RYTM has less debt than TNGX: RYTM (4.03M) vs TNGX (37.6M). RYTM has higher revenues than TNGX: RYTM (113M) vs TNGX (43.4M).
RYTMTNGXRYTM / TNGX
Capitalization3.44B253M1,361%
EBITDA-237.01M-137.2M173%
Gain YTD2.805-21.359-13%
P/E RatioN/AN/A-
Revenue113M43.4M260%
Total Cash298M293M102%
Total Debt4.03M37.6M11%
FUNDAMENTALS RATINGS
RYTM: Fundamental Ratings
RYTM
OUTLOOK RATING
1..100
76
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
PROFIT vs RISK RATING
1..100
31
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
46
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RYTMTNGX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 6 days ago
84%
Bullish Trend 6 days ago
84%
Momentum
ODDS (%)
Bearish Trend 6 days ago
76%
Bearish Trend 6 days ago
74%
MACD
ODDS (%)
Bearish Trend 6 days ago
78%
Bearish Trend 6 days ago
73%
TrendWeek
ODDS (%)
Bearish Trend 6 days ago
80%
Bearish Trend 6 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 6 days ago
77%
Bearish Trend 6 days ago
87%
Advances
ODDS (%)
Bullish Trend 19 days ago
82%
Bullish Trend 19 days ago
83%
Declines
ODDS (%)
Bearish Trend 10 days ago
80%
Bearish Trend 6 days ago
85%
BollingerBands
ODDS (%)
N/A
Bullish Trend 6 days ago
80%
Aroon
ODDS (%)
Bullish Trend 6 days ago
78%
Bearish Trend 6 days ago
84%
View a ticker or compare two or three
Ad is loading...
RYTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TNGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY611.491.79
+0.29%
SPDR® S&P 500® ETF Trust
AAPL244.47-0.13
-0.05%
Apple
GME26.97-0.03
-0.11%
GameStop Corp
BTC.X95539.550000-233.835940
-0.24%
Bitcoin cryptocurrency
TSLA354.11-1.73
-0.49%
Tesla

RYTM and

Correlation & Price change

A.I.dvisor indicates that over the last year, RYTM has been loosely correlated with RCKT. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if RYTM jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RYTM
1D Price
Change %
RYTM100%
+1.52%
RCKT - RYTM
48%
Loosely correlated
+3.15%
KYMR - RYTM
46%
Loosely correlated
+0.68%
ERAS - RYTM
45%
Loosely correlated
-1.27%
IDYA - RYTM
45%
Loosely correlated
-2.67%
RVMD - RYTM
43%
Loosely correlated
+1.97%
More

TNGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TNGX has been loosely correlated with BNTC. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if TNGX jumps, then BNTC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TNGX
1D Price
Change %
TNGX100%
-1.62%
BNTC - TNGX
33%
Loosely correlated
+0.09%
PGEN - TNGX
33%
Poorly correlated
+3.06%
SNDX - TNGX
31%
Poorly correlated
-2.01%
RENB - TNGX
30%
Poorly correlated
+0.64%
RYTM - TNGX
30%
Poorly correlated
+1.52%
More